{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:43:56Z","timestamp":1768635836823,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Craniopharyngiomas (CP) are rare tumors that serve as a source of significant morbidity despite relatively high survival rates. No analysis based on disease histology has been fully explored.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patients with CP were identified via the Surveillance, Epidemiology, and End Results (SEER) Program regarding the following ICD-O-3 codes: 9350 (CP, not otherwise specified; NOS), 9351 (adamantinomatous CP; ACP), and 9352 (papillary CP; PCP). Demographic and treatment variables were analyzed via Chi-squared tests and ten-year overall survival (10y OS) was assessed via Cox regression and log-rank analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Variation in 10y OS was seen regarding patient age (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), race (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), Grade (<jats:italic>p<\/jats:italic>\u2009=\u20090.010), stage (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and treatment with radiotherapy (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) with Cox regression analysis among the 2,359 patients identified. ACP or CP, NOS histologies were more frequent among patients\u2009&lt;\u200925 years old (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), while ACP was more common among male patients (<jats:italic>p<\/jats:italic>\u2009=\u20090.002) and PCP was less common among Black patients (<jats:italic>p<\/jats:italic>\u2009=\u20090.002). Univariate survival analysis revealed the ACP and CP, NOS histologies had improved 10y OS with treatment with radiotherapy (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 and =\u20090.007, respectively). Finally, surgery was associated with improved 10y OS only among patients with the CP, NOS histology (<jats:italic>p<\/jats:italic>\u2009=\u20090.007).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>No difference in 10-year overall survival was seen regarding histology among diagnosed with craniopharyngioma on multivariate or univariate analysis. Differences in the frequency and survival were found among all three histologies stratified by demographics and treatment. Further investigation into these variables, and among different survival timeframes, is warranted.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11060-025-04988-0","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T05:04:30Z","timestamp":1743138270000},"page":"343-351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Population-based histologic analysis of craniopharyngioma demographics and treatment in the US from 2000 to 2020"],"prefix":"10.1007","volume":"173","author":[{"given":"Kevin E.","family":"Agner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2322-8345","authenticated-orcid":false,"given":"Michael C.","family":"Larkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"4988_CR1","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1097\/SCS.0000000000005136","volume":"30","author":"M Kili\u00e7","year":"2019","unstructured":"Kili\u00e7 M, Can SM, \u00d6zdemir B, Tanik C (2019) Management of craniopharyngioma. J Craniofac Surg 30:e178\u2013e183","journal-title":"J Craniofac Surg"},{"key":"4988_CR2","unstructured":"Ortiz Torres M, Shafiq I, Mesfin FB Craniopharyngioma. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Apr 25]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459371\/"},{"key":"4988_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrendo.2016.217","volume":"13","author":"HL M\u00fcller","year":"2017","unstructured":"M\u00fcller HL, Merchant TE, Puget S, Martinez-Barbera J-P (2017) New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nat Rev Endocrinol 13:299\u2013312","journal-title":"Nat Rev Endocrinol"},{"key":"#cr-split#-4988_CR4.1","doi-asserted-by":"crossref","unstructured":"Saeger W, Buslei R (2021) Pathology of nonadenomatous pituitary tumors and tumor-like lesions. Pituit Tumors [Internet]. Elsevier","DOI":"10.1016\/B978-0-12-819949-7.00030-5"},{"key":"#cr-split#-4988_CR4.2","unstructured":"[cited 2024 Apr 24]. pp. 393-404. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128199497000305"},{"key":"4988_CR5","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1055\/s-0036-1588060","volume":"77","author":"J Lubuulwa","year":"2016","unstructured":"Lubuulwa J, Lei T (2016) Pathological and topographical classification of craniopharyngiomas: A literature review. J Neurol Surg Rep 77:e121\u2013e127","journal-title":"J Neurol Surg Rep"},{"key":"4988_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jss.2018.01.029","volume":"226","author":"G Wang","year":"2018","unstructured":"Wang G, Zhang X, Feng M, Guo F (2018) Comparing survival outcomes of gross total resection and subtotal resection with radiotherapy for craniopharyngioma: a meta-analysis. J Surg Res 226:131\u2013139","journal-title":"J Surg Res"},{"key":"4988_CR7","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1016\/j.wneu.2023.03.100","volume":"175","author":"J Pham","year":"2023","unstructured":"Pham J, Rhee B, Malpass R, Ozcan EE, Shaaya E, Doberstein C et al (2023) Marital status independently predicts mortality in adult patients with craniopharyngioma: A SEER-Based study. World Neurosurg 175:e367\u2013e379","journal-title":"World Neurosurg"},{"key":"4988_CR8","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.2147\/IJGM.S320643","volume":"14","author":"H Teng","year":"2021","unstructured":"Teng H, Liu Z, Yan O, He W, Jie D, Qie Y et al (2021) Nomograms for predicting overall survival among patients with craniopharyngiomas at initial diagnosis: A SEER Population-Based analysis. Int J Gen Med 14:3517\u20133527","journal-title":"Int J Gen Med"},{"key":"4988_CR9","doi-asserted-by":"publisher","first-page":"e29777","DOI":"10.1097\/MD.0000000000029777","volume":"101","author":"Y Wu","year":"2022","unstructured":"Wu Y, Xu B, Hu S, Shao B-B (2022) Risk factors for and predictive nomogram of overall survival in adult patients with craniopharyngiomas: A SEER population-based study. Med (Baltim) 101:e29777","journal-title":"Med (Baltim)"},{"key":"4988_CR10","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/neuonc\/nos142","volume":"14","author":"BE Zacharia","year":"2012","unstructured":"Zacharia BE, Bruce SS, Goldstein H, Malone HR, Neugut AI, Bruce JN (2012) Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program. Neuro-Oncol 14:1070\u20131078","journal-title":"Neuro-Oncol"},{"key":"4988_CR11","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1016\/j.wneu.2019.08.209","volume":"133","author":"HJ Park","year":"2020","unstructured":"Park HJ, Dho Y-S, Kim JH, Kim JW, Park C-K, Kim YH (2020) Recurrence rate and prognostic factors for the adult craniopharyngiomas in Long-Term Follow-Up. World Neurosurg 133:e211\u2013e217","journal-title":"World Neurosurg"},{"key":"4988_CR12","unstructured":"Surveillance E, Results E (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Data, 17 Registries, Nov 2022 Sub (2000\u20132020) - Linked To County Attributes - Time Dependent (1990\u20132021) Income\/Rurality, 1969\u20132021 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2023, based on the November 2022 submission"},{"key":"4988_CR13","unstructured":"Adamo M, Groves C, Dickie L, Ruhl J (September 2021) SEER program coding and staging manual 2022. U.S. Department of Health and Human Services National Institutes of Health National Cancer Institute. National Cancer Institute, Bethesda, MD 20892"},{"key":"4988_CR14","unstructured":"Ruhl J, Ward E, Hofferkamp J et al (February 2019). Grade manual. NAACCR, Springfield, IL 62704\u2013\u20094194"},{"key":"4988_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/brainsci13030515","volume":"13","author":"G Jannelli","year":"2023","unstructured":"Jannelli G, Calvanese F, Paun L, Raverot G, Jouanneau E (2023) Current advances in papillary craniopharyngioma: State-Of-The-Art therapies and overview of the literature. Brain Sci 13:515","journal-title":"Brain Sci"},{"key":"4988_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00381-012-1926-2","volume":"29","author":"AJ Clark","year":"2013","unstructured":"Clark AJ, Cage TA, Aranda D, Parsa AT, Sun PP, Auguste KI et al (2013) A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 29:231\u2013238","journal-title":"Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg"},{"key":"4988_CR17","unstructured":"Agner KE, Larkins MC, Adamantinoma (2024) A SEER-based Epidemiological Analysis. Indian J Surg Oncol [Internet]. [cited 2024 Jun 29]; Available from: https:\/\/link.springer.com\/10.1007\/s13193-024-02002-z"},{"key":"4988_CR18","doi-asserted-by":"publisher","first-page":"1272740","DOI":"10.3389\/fonc.2023.1272740","volume":"13","author":"JA Ford","year":"2023","unstructured":"Ford JA, Bhatt A, Kim RC, Larkins M, Burke AM (2023) Primary squamous cell carcinoma of the pancreas: an update on a rare neoplasm from the SEER database. Front Oncol 13:1272740","journal-title":"Front Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-04988-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-04988-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-04988-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T08:44:39Z","timestamp":1748249079000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-04988-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["4988"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-04988-0","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"30 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All personal identifying information for patients was anonymized by Surveillance, Epidemiology, and End Results, thus ethical approval and informed consent were waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived due to approved use of publicly accessible database and retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Consent to publish was waived due to approved use of publicly accessible database and retrospective nature of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}